Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Gastroenterology|November 26, 2008
High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assayHongzhi Zou, William R Taylor, Jonathan J Harrington, et al.
Journal of the National Cancer Institute|June 2, 2005
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrenceDavid S Alberts, María Elena Martínez, Lisa M Hess, et al.
Trials|August 14, 2016
Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trialPhyllis J Goodman, Catherine M Tangen, Amy K Darke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 28, 2016
Shifts in the Fecal Microbiota Associated with Adenomatous PolypsVanessa L Hale, Jun Chen, Stephen Johnson, et al.
Circulation|April 2, 2008
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysisScott D Solomon, Janet Wittes, Peter V Finn, et al.
Annals of Internal Medicine|October 8, 2008
Stool DNA and occult blood testing for screen detection of colorectal neoplasiaDavid A Ahlquist, Daniel J Sargent, Charles L Loprinzi, et al.
Annals of Internal Medicine|March 19, 2008
Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 yearsAdeyinka O Laiyemo, Gwen Murphy, Paul S Albert, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 9, 2008
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trialFrank L Meyskens, Christine E McLaren, Daniel Pelot, et al.
Journal of the National Cancer Institute|August 18, 2016
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled TrialPatricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Journal of the National Cancer Institute|August 18, 2016
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 DiabetesPatricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Pageof 9